Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor

Inflammation

Volumn 35, Issue 1, 2012, Pages 308-315

  Xu, Ling Fen ^a   Teng, Xu ^a   Guo, Jing ^a   Sun, Mei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Claudin 1; Intestinal trefoil factor; Platelet activating factor; Tight junction; Transepithelial electrical resistance; ZO 1

Indexed keywords

CLAUDIN 1; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; INTESTINAL TREFOIL FACTOR; LUCIFER YELLOW; MESSENGER RNA; PROTEIN ZO1; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CELL STRAIN CACO 2; CELL STRUCTURE; CELLULAR PARAMETERS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; INTESTINE MUCOSA PERMEABILITY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION; TRANSEPITHELIAL ELECTRICAL RESISTANCE; WESTERN BLOTTING;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL LINE, TUMOR; ELECTRIC IMPEDANCE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; PEPTIDES; PHOSPHOPROTEINS; PLATELET ACTIVATING FACTOR; TIGHT JUNCTIONS;

LOTUS;

EID: 84859430262     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9320-x     Document Type: Article

References (27)

1. McGuckin, M.A., R. Eri, L.A. Simms, T.H. Florin, and G. Radford-Smith. 2009. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflammatory Bowel Diseases 15: 100-113.
2. Xavier, R.J., and D.K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434. (Pubitemid 47123518)
3. Buhner, S., C. Buning, J. Genschel, K. Kling, D.A. HerrmannD, I. Kuechler, S. Krueger, H.H. Schmidt, and H. Lochs. 2006. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut 55: 342-347. (Pubitemid 43268271)
4. Su, L., L. Shen, D.R. Clayburgh, S.C. Nalle, E.A. Sullivan, J.B. Meddings, C. Abraham, and J.R. Turner. 2009. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology 136: 551-563.
5. Hermiston, M.L., and J.I. Gordon. 1995. Inflammatory bowel disease and adenomas in mice expressing a dominant negative Ncadherin. Science 270: 1203-1207.
6. Renes, I.B., M. Verburg, D.J. Van Nispen, H.A. Büller, J. Dekker, and A.W. Einerhand. 2002. Distict epithelial responses in experimental colitis:implications for ion uptake and mucosal protection. American Journal of Physiology. Gastrointestinal and Liver Physiology 283: G169-G179. (Pubitemid 34666175)
7. Chen, L.P., B.H. Zhang, Y. Li, G.R. Mai, and Z.X. Liu. 2003. The effect and significance of intestinal trefoil factor IL-8 and MDA for neonatal rat model for hypoxia-induced intestinal injury. Chinese Journal of Perinatal Medicine 36: 306-309.
8. Li, J., L.F. Xu, M. Sun, Q. Li, H. Gao, and W.G. Jiang. 2006. Protective effects of recombinant intestinal trefoil factor against intestinal injuries induced by endotoxin in young rats. Chinese Journal of Contemporary Pediatrics 8: 425-428. (Pubitemid 44649863)
9. Hidalgo, I.J., T.J. Raub, and R.T. Borchardt. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96: 736-749. (Pubitemid 19057595)
10. Thim, L. 1997. Trefoil peptides: From structure to function. Cellular and Molecular Life Sciences 53: 888-903. (Pubitemid 28021502)
11. Thim, L. 1994. Trefoil peptides: A new family of gastrointestinal molecules. Digestion 55: 353-360.
12. Suemori, S., K. Lynch-Devaney, and D.K. Podolsky. 1991. Identification and characterization of rat intestinal trefoil factor: Tissue and cell-specific. Proceedings of the National Academy of Sciences of the United States of America 88: 11017-11021. (Pubitemid 21915970)
13. zum Büschenfelde Meyer, D., R. Tauber, and O. Huber. 2006. TFF3- peptide increases transepithelial resistance in epithelial cells by modulating claudin-1 and -2 expression. Peptides 27: 3383-3390.
14. Poritz, L.S., K.I. Garver, C. Green, L. Fitzpatrick, F. Ruggiero, and W.A. Koltun. 2007. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. The Journal of Surgical Research 140: 12-19. (Pubitemid 46669536)
15. Weber, C.R., S.C. Nalle, M. Tretiakova, D.T. Rubin, and J.R. Turner. 2008. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Laboratory Investigation 88: 1110-1120.
16. Hsueh, W., M.S. Caplan, X. Sun, X. Tan, W. MacKendrick, and F. Gonzalez-Crussi. 1994. Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. Acta Paediatrica. Supplement 396: 11-17. (Pubitemid 24186052)
17. Qu, X., L. Huang, T. Burthart, S.E. Crawford, M.S. Caplan, and W. Hsueh. 1996. Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method. Prostaglandins 51: 249-262.
18. Guerrant, R.L., G.D. Fang, N.M. Thielman, and M.C. Fonteles. 1994. Role of platelet activating factor in the intestinal epithelial secretory and chinese hamster ovary cell cytoskeletal responses to cholera toxin. Proceedings of the National Academy of Sciences of the United States of America 91: 9655-9658. (Pubitemid 24297974)
19. Kotelevets, L., V. Noë, E. Bruyneel, E. Myssiakine, E. Chastre, M. Mareel, and C. Gespach. 1998. Inhibition by platelet-activating factor of src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3′- kinase is a critical mediator of tumor invasion. Journal of Biological Chemistry 273: 14138-14145.
20. Merendino, N., M.B. Dwinell, N. Varki, L. Eckmann, and M.F. Kagnoff. 1999. Human intestinal epithelial cells express receptors for platelet-activating factor. The American Journal of Physiology 277: G810-G818. (Pubitemid 29525932)
21. Kubes, P., K.E. Arfors, and D.N. Granger. 1991. Platelet-activating factor-induced mucosal dysfunction: role of oxidants and granulocytes. The American Journal of Physiology 260: G965-G971.
22. Huber, J.D., K.A. Witt, S. Hom, R.D. Egleton, K.S. Mark, and T.P. Davis. 2001. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. American Journal of Physiology. Heart and Circulatory Physiology 280: H1241-H1248.
23. Luabeya, M.K., L.M. Dallasta, C.L. Achim, C.D. Pauza, and R.L. Hamilton. 2000. Blood-brain barrier disruption in simian immunodeficiency virus encephalitis. Neuropathology and Applied Neurobiology 26: 454-462.
24. Song, L., S. Ge, and J.S. Pachter. 2007. Caveolin-1 regulates expression of junction- associated proteins in brain microvascular endothelial cells. Blood 109: 1515-1523. (Pubitemid 46239584)
25. McCarthy, K.M., I.B. Skare, M.C. Stankewich, M. Furuse, S. Tsukita, R.A. Rogers, R.D. Lynch, and E.E. Schneeberger. 1996. Occludin is a functional component of the tight junction. Journal of Cell Science 109: 2287-2298. (Pubitemid 26325491)
26. Han, X., M.P. Fink, and R.L. Delude. 2003. Proinflammatory cytokines cause NO-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19: 229-237.
27. Sappington, P.L., X. Han, R. Yang, R.L. Delude, and M.P. Fink. 2003. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. The Journal of Pharmacology and Experimental Therapeutics 304: 464-476. (Pubitemid 36013435)